Phenotypic and Functional Analysis of Immune CD8+ T Cell Responses Induced by a Single Injection of a HIV DNA Vaccine in Mice

Journal of Immunology

Volumn 178, Issue 4, 2007, Pages 2318-2327

  Arrode, Geraldine ^a   Hegde, Ramakrishna ^a   Mani, Arunmani ^a   Jin, Yuhuai ^a   Chebloune, Yahia ^a,b   Narayan, Opendra ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b CEMAGREF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; GRANZYME B; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ANIMAL EXPERIMENT; ARTICLE; BAGG ALBINO MOUSE; CD8+ T LYMPHOCYTE; CELL KINETICS; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSPOT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNIZATION; IMMUNOLOGICAL MEMORY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION;

EID: 33846925654     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.4.2318     Document Type: Article

References (42)

1. + T cell proliferation is coupled to perform expression and is maintained in nonprogressors. Nat. Immunol. 3: 1061-1068.
2. Zimmerli, S. C., A. Harari, C. Cellerai, F. Vallelian, P. A. Bart, and G. Pantaleo. 2005. HIV-1-specific IFN-γ/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. Pro. Natl. Acad. Sci. USA 102: 7239-7244.
3. + T cells from most HIV-1-infected patients, even when challenged with mature dendritic cells, lack functional recall memory to HIV gag but not other viruses. Eur. J. Immunol. 35: 159-170.
4. + T cells. Blood 107: 4781-4789.
5. + elite suppressors despite CTL escape mutations. J. Exp. Med. 203: 1357-1369.
6. + T cells and viremia: who's in control? Trends Immunol. 27: 119-124.
7. Pantaleo, G., and R. A. Koup. 2004. Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know. Nat. Med. 10: 806-810.
8. Koup, R. A., C. A. Pikora, G. Mazzara, D. Panicali, and J. L. Sullivan. 1991. Broadly reactive antibody-dependent cellular cytotoxic response to HIV-1 envelope glycoproteins precedes broad neutralizing response in human infection. Viral Immunol. 4: 215-223.
9. Hassett, D. E., J. Zhang, M. Slifka, and J. L. Whitton. 2000. Immune responses following neonatal DNA vaccination are long-lived, abundant, and qualitatively similar to those induced by conventional immunization. J. Virol. 74: 2620-2627.
10. + T cell epitopes. J. Virol. 80: 4717-4728.
11. Mulligan, M. J., N. D. Russell, C. Celum, J. Kahn, E. Noonan, D. C. Montefiori, G. Ferrari, K. J. Weinhold, J. M. Smith, R. R. Amara, and H. L. Robinson. 2006. Excellent safety and tolerability of the human immunodeficiency virus type 1 pGA2/JS2 plasmid DNA priming vector vaccine in HIV type 1 uninfected adults. AIDS Res. Hum. Retroviruses 22: 678-683.
12. Hegde, R., Z. Liu, G. Mackay, M. Smith, Y. Chebloune, O. Narayan, and D. K. Singh. 2005. Antigen expression kinetics and immune responses of mice immunized with noninfectious simian-human immunodeficiency virus DNA. J. Virol. 79: 14688-14697.
13. Liu, Z., D. K. Singh, D. Sheffer, M. S. Smith, S. Dhillon, Y. Chebloune, R. Hegde, S. Buch, and O. Narayan. 2006. Immunoprophylaxis against AIDS in macaques with a lentiviral DNA vaccine. Virology 351: 444-454.
14. Hudgens, M. G., S. G. Self, Y. L. Chiu, N. D. Russell, H. Horton, and M. J. McElrath. 2004. Statistical considerations for the design and analysis of the ELISpot assay in HIV-1 vaccine trials. J. Immunol. Methods 288: 19-34.
15. Mwau, M., A. J. McMichael, and T. Hanke. 2002. Design and validation of an enzyme-linked immunospot assay for use in clinical trials of candidate HIV vaccines. AIDS Res. Hum. Retroviruses 18: 611-618.
16. Seaman, M. S., F. W. Peyerl, S. S. Jackson, M. A. Lifton, D. A. Gorgone, J. E. Schmitz, and N. L. Letvin. 2004, Subsets of memory cytotoxic T lymphocytes elicited by vaccination influence the efficiency of secondary expansion in vivo. J. Virol. 78: 206-215.
17. Perfetto, S. P., P. K. Chattopadhyay, and M. Roederer. 2004. Seventeen-colour flow cytometry: unravelling the immune system. Nat. Rev. Immunol. 4: 648-655.
18. Singh, D. K., Z. Liu, D. Sheffer, G. A. Mackay, M. Smith, S. Dhillon, R. Hegde, F. Jia, I. Adany, and O. Narayan. 2005. A noninfectious simian/human immunodeficiency virus DNA vaccine that protects macaques against AIDS. J. Virol. 79: 3419-3428.
19. Zaph, C., J. Uzonna, S. M. Beverley, and P. Scott. 2004. Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites. Nat. Med. 10: 1104-1110.
20. Williams, M. A., and M. J. Bevan. 2004. Shortening the infectious period does not alter expansion of CD8 T cells but diminishes their capacity to differentiate into memory cells. J. Immunol. 173: 6694-6702.
21. Wherry, E. J., V. Teichgraber, T. C. Becker, D. Masopust, S. M. Kaech, R. Antia, U. H. von Andrian, and R. Ahmed. 2003. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4: 225-234.
22. Pardini, M., F. Giannoni, C. Palma, E. Iona, A. Cafaro, L. Brunori, M. Rinaldi, V. M. Fazio, M. E. Laguardia, D. C. Carbonella, et al. 2006. Immune response and protection by DNA vaccines expressing antigen 85B of Mycobacterium tuberculosis. FEMS Microb. Lett. 262: 210-215.
23. Boyer, J. D., K. E. Ugen, B. Wang, M. Agadjanyan, L. Gilbert, M. L. Bagarazzi, M. Chattergoon, P. Frost, A. Javadian, W. V. Williams, et al. 1997. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nat. Med. 3: 526-532.
24. Egan, M. A., W. A. Pavlat, J. Tartaglia, E. Paoletti, K. J. Weinhold, M. L. Clements, and R. F. Siliciano. 1995. Induction of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T lymphocyte responses in seronegative adults by a nonreplicating, host-range-restricted canarypox vector (ALVAC) carrying the HIV-1MN env gene. J. Infect. Dis. 171: 1623-1627.
25. Musey, L., Y. Ding, M. Elizaga, R. Ha, C. Celum, and M. J. McElrath. 2003. HIV-1 vaccination administered intramuscularly can induce both systemic and mucosal T cell immunity in HIV-1-uninfected individuals. J. Immunol. 171: 1094-1101.
26. Fuller, D. H., P. A. Rajakumar, M. S. Wu, C. W. McMahon, T. Shipley, J. T. Fuller, A. Bazmi, A. M. Trichel, T. M. Allen, B. Mothe, et al. 2006. DNA immunization in combination with effective antiretroviral drug therapy controls viral rebound and prevents simian AIDS after treatment is discontinued. Virology 348: 200-215.
27. Rao, S. S., P. Gomez, J. R. Mascola, V. Dang, G. R. Krivulka, F. Yu, C. I. Lord, L. Shen, R. Bailer, G. J. Nabel, and N. L. Letvin. 2006. Comparative evaluation of three different intramuscular delivery methods for DNA immunization in a nonhuman primate animal model. Vaccine 24: 367-373.
28. McMichael, A. J. 2006. HIV vaccines. Annu. Rev. Immunol. 24: 227-255.
29. Appay, V., L. Papagno, C. A. Spina, P. Hansasuta, A. King, L. Jones, G. S. Ogg, S. Little, A. J. McMichael, D. D. Richman, and S. L. Rowland-Jones. 2002. Dynamics of T cell responses in HIV infection. J. Immunol. 168: 3660-3666.
30. + T cell responses: relationship to viral load in untreated HIV infection. J. Virol. 75: 11983-11991.
31. + T cells in HIV-infected progressors and long-term nonprogressors. J. Immunol. 165: 1082-1092.
32. Singh, R. A., and M. A. Barry. 2004. Repertoire and immunofocusing of CD8 T cell responses generated by HIV-1 gag-pol and expression library immunization vaccines. J. Immunol. 173: 4387-4393.
33. + T cells with potent recall function. J. Immunol. 177: 6730-6737.
34. Masopust, D., S. J. Ha, V. Vezys, and R. Ahmed. 2006. Stimulation history dictates memory CD8 T cell phenotype: implications for prime-boost vaccination. J. Immunol. 177: 831-839.
35. Zajac, A. J., J. N. Blattman, K. Murali-Krishna, D. J. Sourdive, M. Suresh, J. D. Altman, and R. Ahmed. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188: 2205-2213.
36. Lu, W., L. C. Arraes, W. T. Ferreira, and J. M. Andrieu. 2004. Therapeutic dendritic-cell vaccine for chronic HIV-1 infection. Nat Med. 10: 1359-1365.
37. + T cells. J. Exp. Med. 200: 701-712.
38. Kutzler, M. A., T. M. Robinson, M. A. Chattergoon, D. K. Choo, A. Y. Choo, P. Y. Choe, M. P. Ramanathan, R. Parkinson, S. Kudchodkar, Y. Tamura, et al. 2005. Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help. J. Immunol. 175: 112-123.
39. Manjunath, N., P. Shankar, J. Wan, W. Weninger, M. A. Crowley, K. Hieshima, T. A. Springer, X. Fan, H, Shen, J. Lieberman, and U. H. von Andrian. 2001. Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes. J. Clin. Invest. 108: 871-878.
40. Kalia, V., S. Sarkar, T. S. Gourley, B. T. Rouse, and R. Ahmed. 2006. Differentiation of memory B and T cells. Curr. Opin. Immunol. 18: 255-264.
41. Horton, H., C. Havenar-Daughton, D. Lee, E. Moore, J. Cao, J. McNevin, T. Andrus, H. Zhu, A. Rubin, T. Zhu, et al. 2006. Induction of human immunodeficiency virus type 1 (HIV-1)-specific T cell responses in HIV vaccine trial participants who subsequently acquire HIV-1 infection. J. Virol. 80: 9779-9788.
42. De Rosa, S. C., F. X. Lu, J. Yu, S. P. Perfetto, J. Falloon, S. Moser, T. G. Evans, R. Koup, C. J. Miller, and M. Roederer. 2004. Vaccination in humans generates broad T cell cytokine responses. J. Immunol. 173: 5372-5380.